Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00929747 |
Recruitment Status :
Withdrawn
(Management Decision)
First Posted : June 29, 2009
Last Update Posted : April 12, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cataracts | Device: Toric Procedure: Limbal Relaxing Incision | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus LRI Patients |
Study Start Date : | June 2009 |
Actual Primary Completion Date : | October 2009 |
Actual Study Completion Date : | October 2009 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Toric IOL
AcrySof IQ Toric IOL
|
Device: Toric
Unilateral implantation of the AcrySof IQ Toric IOL |
Active Comparator: Limbal Relaxing Incision
AcrySof IQ with Limbal Relaxing Incision
|
Procedure: Limbal Relaxing Incision
Unilateral implantation of a AcrySof IQ (SN60WF) IOL with concomitant LRI at the time of surgery |
- Corneal aberration [ Time Frame: 3 months ]
- Visual acuity [ Time Frame: 3 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- operable cataracts
- good ocular health
- 0.5 D to 2.0 D of corneal astigmatism
Exclusion Criteria:
- > 2.0 D astigmatism
- irregular astigmatism
- prior or ongoing corneal disease or scarring
- history of ocular disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00929747
United States, Texas | |
Alcon Call Center for Trial Locations | |
Fort Worth, Texas, United States, 76134 |
Responsible Party: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00929747 |
Other Study ID Numbers: |
M08-008 |
First Posted: | June 29, 2009 Key Record Dates |
Last Update Posted: | April 12, 2012 |
Last Verified: | October 2009 |
Cataract Toric IOL AcrySof, LRI |
Cataract Lens Diseases Eye Diseases |